DAVPX
Price
$36.26
Change
-$1.10 (-2.94%)
Updated
Dec 18 closing price
VITSX
Price
$141.31
Change
-$4.59 (-3.15%)
Updated
Dec 18 closing price
Ad is loading...

DAVPX vs VITSX

Header iconDAVPX vs VITSX Comparison
Open Charts DAVPX vs VITSXBanner chart's image
Davenport Core Leaders Fund
Price$36.26
Change-$1.10 (-2.94%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Market Idx I
Price$141.31
Change-$4.59 (-3.15%)
VolumeN/A
CapitalizationN/A
DAVPX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DAVPX vs. VITSX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAVPX is a Buy and VITSX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.84T vs. DAVPX (1.13B). VITSX pays higher dividends than DAVPX: VITSX (1.36) vs DAVPX (0.28). DAVPX was incepted earlier than VITSX: DAVPX (27 years) vs VITSX (27 years). DAVPX is a more actively managed with annual turnover of: 19.00 vs. VITSX (2.00). DAVPX has a lower initial minimum investment than VITSX: DAVPX (5000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 26.92 vs. DAVPX (19.38). VITSX return over 5 years is better than : 84.17 vs. DAVPX (41.11).
DAVPXVITSXDAVPX / VITSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years27 years-
Gain YTD18.41826.39570%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B1.84T0%
Annual Yield % from dividends0.281.3620%
Returns for 1 year19.3826.9272%
Returns for 3 years13.0727.8947%
Returns for 5 years41.1184.1749%
Returns for 10 years97.66192.7351%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIVC0.230.01
+3.77%
Tivic Health Systems
THRD11.350.23
+2.07%
Third Harmonic Bio
VRNT29.420.36
+1.24%
Verint Systems
PEN247.550.31
+0.13%
Penumbra
CNTX1.29-0.07
-5.15%
Context Therapeutics